Media Centre

This Media centre is for NDLR relevant industry news provided by the NDLR Organising Committee Members, Media Partners, Sponsors and Exhibitors. If you wish to submit an article for consideration please email the details to the NDLR Meeting Organiser at

 See Kimberly Stegmaire, one of NDLR 2018 invited speakers paper on  Fred Hutch researchers engineer complex TCR immunotherapy that may target relapsing leukemia

See Kimberly Stegmaire, one of NDLR 2018 invited speakers paper on  Cancer researchers hit a bullseye with new drug target for Ewing sarcoma.

See Bruce Levine, one of NDLR 2018 invited speakers webinar  on “What’s next for CAR T Cell Immunotherapy.

July 3, 2017

Charting the genomic landscape of T-lineage acute lymphoblastic leukemia patients revealed insights that will guide research and help to lay the foundation for more targeted therapy.

Genomic analysis of key acute leukemia will likely yield new therapies

June 28, 2017

Stem-cell researchers solve mystery of relapse in acute myeloid leukemia.

Leukemia researchers led by Dr. John Dick have traced the origins of relapse in acute myeloid leukemia (AML) to rare therapy-resistant leukemia stem cells that are already present at diagnosis and before chemotherapy begins.

June 13, 2017

New frontier in cancer care: Turning blood into living drugs

IMMUNE therapy is the hottest trend in cancer care, creating “living drugs” that grow inside the body into an army that destroys tumours and “melt away” cancer.

March 08 2017

11 year study shows an estimated overall survival rate of 83.3 % according to National Cancer Institute.

New England Journal of medicine publishes long-term results of Gleevec® for patients with chronic myeloid leukemia.